Influence of low-dose i.v. growth hormone treatment together with glutamine supplementation in late-phase critically ill patient after multiple injury. A pilot study. - AGHATA
- Conditions
- Prolonged phase of critical illness after severe multiple trauma
- Registration Number
- EUCTR2004-004727-36-CZ
- Lead Sponsor
- Charles University, 3rd Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- 30
Multiple trauma patients admitted to Dept. of Anaesthesia and Criticla Care Medicine of Kralovske Vinohrady University Hospital, Prague. Age 18-60 years, both sexes, on the 4th day after injury expected to stay at least a week in the ICU. Written informed consent (given by the closest relative in inconcious subjects).
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Diabetes mellitus or other known endocrinopathy, gravidity, known allergy to growth hormone), head injury involving hypothalamo-pituitary region, treatment of immune suppresants of high-dose corticoids.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method